Advertisement
Advertisement
U.S. Markets close in 4 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Willow Biosciences Inc. (CANSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1365+0.0038 (+2.86%)
As of 10:04AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1327
Open0.1365
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1365 - 0.1365
52 Week Range0.1220 - 1.0900
Volume120
Avg. Volume31,829
Market Cap16.864M
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)-0.1140
Earnings DateMar 21, 2022 - Mar 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
  • CNW Group

    WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS

    Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general meeting of shareholders held on May 13, 2022 (the "Meeting"). A total of 42,387,564 common shares, representing approximately 34.31% of the Company's issued and outstanding shares were represented at the meeting.

  • CNW Group

    WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2022 RESULTS

    Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally derived from plants, has released its financial and operating results for the three months ended March 31, 2022, reporting significant progress to its operational platform and strong liquidity.

  • CNW Group

    WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATION

    Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally derived from plants, announces expanded production capacity with a new manufacturing partnership and progress with respect to its Generally Recognized as Safe ("GRAS") determination.

Advertisement
Advertisement